The government of Taiwan has designated pharmaceuticals as a key industry for development, and this includes preferential treatment in taxation, financing and technical consultations, according to a recent report in the Free China Journal.
Health care goods are soaring in demand in Taiwan, the report notes, with imports of medicines alone in 1993 amounting to $483 million, which is said to represent around one-third of the nation's total consumption of medicines in that year. Japan has replaced the USA as the main source.
Meantime, Taiwan's exports of medicines also increased, by 8%, to reach a value of $63 million.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze